Why do cancer drugs get such an easy ride?
BMJ
.
2015 Apr 23:350:h2068.
doi: 10.1136/bmj.h2068.
Authors
Donald W Light
1
,
Joel Lexchin
2
Affiliations
1
School of Osteopathic Medicine, Rowan University, Cherry Hill, NJ 08002, USA dlight@princeton.edu.
2
School of Health Policy and Management, York University, Toronto, ON, Canada.
PMID:
25908437
DOI:
10.1136/bmj.h2068
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents*
Clinical Trials, Phase III as Topic
Drug Approval*
Drug Industry*
Humans
Quality Assurance, Health Care
Quality Improvement
Substances
Antineoplastic Agents